OM1 focuses on enhancing patient outcomes in healthcare through data analytics and artificial intelligence. The company specializes in chronic diseases, utilizing real-world data (RWD) collected from sources like electronic health records and insurance claims to generate real-world evidence (RWE). This evidence helps understand treatment effectiveness in everyday clinical settings. OM1's key product, Aspen, is an automated platform that predicts patient outcomes and provides insights for healthcare decisions. Unlike competitors, OM1 emphasizes the use of AI to identify patients with specific conditions and forecast treatment results, allowing for more tailored care. The company's goal is to improve patient outcomes and support the development of new treatments by providing actionable insights.